(MedPage Today) -- Generic versions of popular opioid painkillers OxyContin and Opana are slated to begin coming to market this month, but makers of the brand products warn that the non-tamper-resistant newcomers are unsafe, and some legislators are concerned as well. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment